AAI
BLUE

Aequim Alternative Investments’s bluebird bio BLUE Stock Holding History

Aequim Alternative Investments’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-983
Closed -$243K – 123
2021
Q3 		$243K Buy
+983
New +$281K 0.01% 99

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aequim Alternative Investments's BLUE Position: Q4 2021 in Review

Aequim Alternative Investments sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 983 shares — an estimated $243K sold.

Aequim Alternative Investments first reported a position in BLUE in Q3 2021 and held it in 1 quarter. The position peaked at $243K in Q3 2021. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • Aequim Alternative Investments reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • Aequim Alternative Investments sold 983 bluebird bio shares in Q4 2021, an estimated $243K.
  • Aequim Alternative Investments first reported a position in bluebird bio in Q3 2021 and held it in 1 quarter.
  • Aequim Alternative Investments's bluebird bio position peaked at $243K in Q3 2021.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on Aequim Alternative Investments's 13F filing for Q4 2021, filed 9 Feb 2022.